Global Nuclear Medicine Radioisotopes Market Research Report 2025(Status and Outlook)
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
The global Nuclear Medicine Radioisotopes market size was estimated at USD 3450.31 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 0.03% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine Radioisotopes market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine Radioisotopes market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine Radioisotopes market.
Global Nuclear Medicine Radioisotopes Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market Segmentation (by Type)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market Segmentation (by Application)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radioisotopes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine Radioisotopes, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nuclear Medicine Radioisotopes market size was estimated at USD 3450.31 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 0.03% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nuclear Medicine Radioisotopes market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nuclear Medicine Radioisotopes market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nuclear Medicine Radioisotopes market.
Global Nuclear Medicine Radioisotopes Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
Market Segmentation (by Type)
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Market Segmentation (by Application)
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Medicine Radioisotopes Market
- Overview of the regional outlook of the Nuclear Medicine Radioisotopes Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Radioisotopes Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nuclear Medicine Radioisotopes, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radioisotopes
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radioisotopes Segment by Type
1.2.2 Nuclear Medicine Radioisotopes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOISOTOPES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOISOTOPES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine Radioisotopes Product Life Cycle
3.3 Global Nuclear Medicine Radioisotopes Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
3.8.1 Nuclear Medicine Radioisotopes Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOISOTOPES INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOISOTOPES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine Radioisotopes Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine Radioisotopes Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine Radioisotopes Market Size Market Share by Type (2020-2025)
6.4 Global Nuclear Medicine Radioisotopes Price by Type (2020-2025)
7 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radioisotopes Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine Radioisotopes Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE RADIOISOTOPES MARKET SALES BY REGION
8.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Region
8.2 Global Nuclear Medicine Radioisotopes Market Size by Region
8.2.1 Global Nuclear Medicine Radioisotopes Market Size by Region
8.2.2 Global Nuclear Medicine Radioisotopes Market Size Market Share by Region
8.3 North America
8.3.1 North America Nuclear Medicine Radioisotopes Sales by Country
8.3.2 North America Nuclear Medicine Radioisotopes Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine Radioisotopes Sales by Country
8.4.2 Europe Nuclear Medicine Radioisotopes Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region
8.5.2 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine Radioisotopes Sales by Country
8.6.2 South America Nuclear Medicine Radioisotopes Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE RADIOISOTOPES MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine Radioisotopes by Region(2020-2025)
9.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine Radioisotopes Production
9.4.1 North America Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine Radioisotopes Production
9.5.1 Europe Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine Radioisotopes Production (2020-2025)
9.6.1 Japan Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine Radioisotopes Production (2020-2025)
9.7.1 China Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agfa-Gevaert Group
10.1.1 Agfa-Gevaert Group Basic Information
10.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
10.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Market Performance
10.1.4 Agfa-Gevaert Group Business Overview
10.1.5 Agfa-Gevaert Group SWOT Analysis
10.1.6 Agfa-Gevaert Group Recent Developments
10.2 Braco
10.2.1 Braco Basic Information
10.2.2 Braco Nuclear Medicine Radioisotopes Product Overview
10.2.3 Braco Nuclear Medicine Radioisotopes Product Market Performance
10.2.4 Braco Business Overview
10.2.5 Braco SWOT Analysis
10.2.6 Braco Recent Developments
10.3 Cardiarc
10.3.1 Cardiarc Basic Information
10.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Overview
10.3.3 Cardiarc Nuclear Medicine Radioisotopes Product Market Performance
10.3.4 Cardiarc Business Overview
10.3.5 Cardiarc SWOT Analysis
10.3.6 Cardiarc Recent Developments
10.4 Cardinal Health
10.4.1 Cardinal Health Basic Information
10.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Overview
10.4.3 Cardinal Health Nuclear Medicine Radioisotopes Product Market Performance
10.4.4 Cardinal Health Business Overview
10.4.5 Cardinal Health Recent Developments
10.5 CMR Naviscan (Gamma Medica Inc.)
10.5.1 CMR Naviscan (Gamma Medica Inc.) Basic Information
10.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
10.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Market Performance
10.5.4 CMR Naviscan (Gamma Medica Inc.) Business Overview
10.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments
10.6 Curium
10.6.1 Curium Basic Information
10.6.2 Curium Nuclear Medicine Radioisotopes Product Overview
10.6.3 Curium Nuclear Medicine Radioisotopes Product Market Performance
10.6.4 Curium Business Overview
10.6.5 Curium Recent Developments
10.7 Digirad
10.7.1 Digirad Basic Information
10.7.2 Digirad Nuclear Medicine Radioisotopes Product Overview
10.7.3 Digirad Nuclear Medicine Radioisotopes Product Market Performance
10.7.4 Digirad Business Overview
10.7.5 Digirad Recent Developments
10.8 GE Healthcare
10.8.1 GE Healthcare Basic Information
10.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Overview
10.8.3 GE Healthcare Nuclear Medicine Radioisotopes Product Market Performance
10.8.4 GE Healthcare Business Overview
10.8.5 GE Healthcare Recent Developments
10.9 Nordion (Canada)
10.9.1 Nordion (Canada) Basic Information
10.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
10.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product Market Performance
10.9.4 Nordion (Canada) Business Overview
10.9.5 Nordion (Canada) Recent Developments
10.10 NTP Radioisotopes SOC
10.10.1 NTP Radioisotopes SOC Basic Information
10.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
10.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Market Performance
10.10.4 NTP Radioisotopes SOC Business Overview
10.10.5 NTP Radioisotopes SOC Recent Developments
10.11 Positron
10.11.1 Positron Basic Information
10.11.2 Positron Nuclear Medicine Radioisotopes Product Overview
10.11.3 Positron Nuclear Medicine Radioisotopes Product Market Performance
10.11.4 Positron Business Overview
10.11.5 Positron Recent Developments
10.12 Segami
10.12.1 Segami Basic Information
10.12.2 Segami Nuclear Medicine Radioisotopes Product Overview
10.12.3 Segami Nuclear Medicine Radioisotopes Product Market Performance
10.12.4 Segami Business Overview
10.12.5 Segami Recent Developments
10.13 Siemens Healthcare
10.13.1 Siemens Healthcare Basic Information
10.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
10.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product Market Performance
10.13.4 Siemens Healthcare Business Overview
10.13.5 Siemens Healthcare Recent Developments
11 NUCLEAR MEDICINE RADIOISOTOPES MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine Radioisotopes Market Size Forecast
11.2 Global Nuclear Medicine Radioisotopes Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region
11.2.4 South America Nuclear Medicine Radioisotopes Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine Radioisotopes by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Type (2026-2033)
12.1.2 Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nuclear Medicine Radioisotopes by Type (2026-2033)
12.2 Global Nuclear Medicine Radioisotopes Market Forecast by Application (2026-2033)
12.2.1 Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application
12.2.2 Global Nuclear Medicine Radioisotopes Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Medicine Radioisotopes
1.2 Key Market Segments
1.2.1 Nuclear Medicine Radioisotopes Segment by Type
1.2.2 Nuclear Medicine Radioisotopes Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE RADIOISOTOPES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Radioisotopes Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Nuclear Medicine Radioisotopes Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE RADIOISOTOPES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nuclear Medicine Radioisotopes Product Life Cycle
3.3 Global Nuclear Medicine Radioisotopes Sales by Manufacturers (2020-2025)
3.4 Global Nuclear Medicine Radioisotopes Revenue Market Share by Manufacturers (2020-2025)
3.5 Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nuclear Medicine Radioisotopes Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nuclear Medicine Radioisotopes Market Competitive Situation and Trends
3.8.1 Nuclear Medicine Radioisotopes Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nuclear Medicine Radioisotopes Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE RADIOISOTOPES INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Radioisotopes Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE RADIOISOTOPES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nuclear Medicine Radioisotopes Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nuclear Medicine Radioisotopes Market
5.7 ESG Ratings of Leading Companies
6 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2025)
6.3 Global Nuclear Medicine Radioisotopes Market Size Market Share by Type (2020-2025)
6.4 Global Nuclear Medicine Radioisotopes Price by Type (2020-2025)
7 NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Radioisotopes Market Sales by Application (2020-2025)
7.3 Global Nuclear Medicine Radioisotopes Market Size (M USD) by Application (2020-2025)
7.4 Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
8 NUCLEAR MEDICINE RADIOISOTOPES MARKET SALES BY REGION
8.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.1 Global Nuclear Medicine Radioisotopes Sales by Region
8.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Region
8.2 Global Nuclear Medicine Radioisotopes Market Size by Region
8.2.1 Global Nuclear Medicine Radioisotopes Market Size by Region
8.2.2 Global Nuclear Medicine Radioisotopes Market Size Market Share by Region
8.3 North America
8.3.1 North America Nuclear Medicine Radioisotopes Sales by Country
8.3.2 North America Nuclear Medicine Radioisotopes Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nuclear Medicine Radioisotopes Sales by Country
8.4.2 Europe Nuclear Medicine Radioisotopes Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nuclear Medicine Radioisotopes Sales by Region
8.5.2 Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nuclear Medicine Radioisotopes Sales by Country
8.6.2 South America Nuclear Medicine Radioisotopes Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region
8.7.2 Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NUCLEAR MEDICINE RADIOISOTOPES MARKET PRODUCTION BY REGION
9.1 Global Production of Nuclear Medicine Radioisotopes by Region(2020-2025)
9.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2025)
9.3 Global Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nuclear Medicine Radioisotopes Production
9.4.1 North America Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.4.2 North America Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nuclear Medicine Radioisotopes Production
9.5.1 Europe Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.5.2 Europe Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nuclear Medicine Radioisotopes Production (2020-2025)
9.6.1 Japan Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.6.2 Japan Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nuclear Medicine Radioisotopes Production (2020-2025)
9.7.1 China Nuclear Medicine Radioisotopes Production Growth Rate (2020-2025)
9.7.2 China Nuclear Medicine Radioisotopes Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Agfa-Gevaert Group
10.1.1 Agfa-Gevaert Group Basic Information
10.1.2 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
10.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Market Performance
10.1.4 Agfa-Gevaert Group Business Overview
10.1.5 Agfa-Gevaert Group SWOT Analysis
10.1.6 Agfa-Gevaert Group Recent Developments
10.2 Braco
10.2.1 Braco Basic Information
10.2.2 Braco Nuclear Medicine Radioisotopes Product Overview
10.2.3 Braco Nuclear Medicine Radioisotopes Product Market Performance
10.2.4 Braco Business Overview
10.2.5 Braco SWOT Analysis
10.2.6 Braco Recent Developments
10.3 Cardiarc
10.3.1 Cardiarc Basic Information
10.3.2 Cardiarc Nuclear Medicine Radioisotopes Product Overview
10.3.3 Cardiarc Nuclear Medicine Radioisotopes Product Market Performance
10.3.4 Cardiarc Business Overview
10.3.5 Cardiarc SWOT Analysis
10.3.6 Cardiarc Recent Developments
10.4 Cardinal Health
10.4.1 Cardinal Health Basic Information
10.4.2 Cardinal Health Nuclear Medicine Radioisotopes Product Overview
10.4.3 Cardinal Health Nuclear Medicine Radioisotopes Product Market Performance
10.4.4 Cardinal Health Business Overview
10.4.5 Cardinal Health Recent Developments
10.5 CMR Naviscan (Gamma Medica Inc.)
10.5.1 CMR Naviscan (Gamma Medica Inc.) Basic Information
10.5.2 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
10.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Market Performance
10.5.4 CMR Naviscan (Gamma Medica Inc.) Business Overview
10.5.5 CMR Naviscan (Gamma Medica Inc.) Recent Developments
10.6 Curium
10.6.1 Curium Basic Information
10.6.2 Curium Nuclear Medicine Radioisotopes Product Overview
10.6.3 Curium Nuclear Medicine Radioisotopes Product Market Performance
10.6.4 Curium Business Overview
10.6.5 Curium Recent Developments
10.7 Digirad
10.7.1 Digirad Basic Information
10.7.2 Digirad Nuclear Medicine Radioisotopes Product Overview
10.7.3 Digirad Nuclear Medicine Radioisotopes Product Market Performance
10.7.4 Digirad Business Overview
10.7.5 Digirad Recent Developments
10.8 GE Healthcare
10.8.1 GE Healthcare Basic Information
10.8.2 GE Healthcare Nuclear Medicine Radioisotopes Product Overview
10.8.3 GE Healthcare Nuclear Medicine Radioisotopes Product Market Performance
10.8.4 GE Healthcare Business Overview
10.8.5 GE Healthcare Recent Developments
10.9 Nordion (Canada)
10.9.1 Nordion (Canada) Basic Information
10.9.2 Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
10.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Product Market Performance
10.9.4 Nordion (Canada) Business Overview
10.9.5 Nordion (Canada) Recent Developments
10.10 NTP Radioisotopes SOC
10.10.1 NTP Radioisotopes SOC Basic Information
10.10.2 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
10.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Market Performance
10.10.4 NTP Radioisotopes SOC Business Overview
10.10.5 NTP Radioisotopes SOC Recent Developments
10.11 Positron
10.11.1 Positron Basic Information
10.11.2 Positron Nuclear Medicine Radioisotopes Product Overview
10.11.3 Positron Nuclear Medicine Radioisotopes Product Market Performance
10.11.4 Positron Business Overview
10.11.5 Positron Recent Developments
10.12 Segami
10.12.1 Segami Basic Information
10.12.2 Segami Nuclear Medicine Radioisotopes Product Overview
10.12.3 Segami Nuclear Medicine Radioisotopes Product Market Performance
10.12.4 Segami Business Overview
10.12.5 Segami Recent Developments
10.13 Siemens Healthcare
10.13.1 Siemens Healthcare Basic Information
10.13.2 Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
10.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Product Market Performance
10.13.4 Siemens Healthcare Business Overview
10.13.5 Siemens Healthcare Recent Developments
11 NUCLEAR MEDICINE RADIOISOTOPES MARKET FORECAST BY REGION
11.1 Global Nuclear Medicine Radioisotopes Market Size Forecast
11.2 Global Nuclear Medicine Radioisotopes Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country
11.2.3 Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region
11.2.4 South America Nuclear Medicine Radioisotopes Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nuclear Medicine Radioisotopes by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Nuclear Medicine Radioisotopes Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Nuclear Medicine Radioisotopes by Type (2026-2033)
12.1.2 Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Nuclear Medicine Radioisotopes by Type (2026-2033)
12.2 Global Nuclear Medicine Radioisotopes Market Forecast by Application (2026-2033)
12.2.1 Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application
12.2.2 Global Nuclear Medicine Radioisotopes Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radioisotopes Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radioisotopes Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine Radioisotopes Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2024)
Table 10. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nuclear Medicine Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nuclear Medicine Radioisotopes Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nuclear Medicine Radioisotopes Sales by Type (K Units)
Table 26. Global Nuclear Medicine Radioisotopes Market Size by Type (M USD)
Table 27. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2020-2025)
Table 28. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2025)
Table 29. Global Nuclear Medicine Radioisotopes Market Size (M USD) by Type (2020-2025)
Table 30. Global Nuclear Medicine Radioisotopes Market Size Share by Type (2020-2025)
Table 31. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2020-2025)
Table 32. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application
Table 33. Global Nuclear Medicine Radioisotopes Market Size by Application
Table 34. Global Nuclear Medicine Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 35. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2025)
Table 36. Global Nuclear Medicine Radioisotopes Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nuclear Medicine Radioisotopes Market Share by Application (2020-2025)
Table 38. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
Table 39. Global Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 40. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2025)
Table 41. Global Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nuclear Medicine Radioisotopes Market Size Market Share by Region (2020-2025)
Table 43. North America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 44. North America Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 46. Europe Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 50. South America Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nuclear Medicine Radioisotopes Production (K Units) by Region(2020-2025)
Table 54. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2025)
Table 56. Global Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Agfa-Gevaert Group Basic Information
Table 62. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
Table 63. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Agfa-Gevaert Group Business Overview
Table 65. Agfa-Gevaert Group SWOT Analysis
Table 66. Agfa-Gevaert Group Recent Developments
Table 67. Braco Basic Information
Table 68. Braco Nuclear Medicine Radioisotopes Product Overview
Table 69. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Braco Business Overview
Table 71. Braco SWOT Analysis
Table 72. Braco Recent Developments
Table 73. Cardiarc Basic Information
Table 74. Cardiarc Nuclear Medicine Radioisotopes Product Overview
Table 75. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Cardiarc Business Overview
Table 77. Cardiarc SWOT Analysis
Table 78. Cardiarc Recent Developments
Table 79. Cardinal Health Basic Information
Table 80. Cardinal Health Nuclear Medicine Radioisotopes Product Overview
Table 81. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Cardinal Health Business Overview
Table 83. Cardinal Health Recent Developments
Table 84. CMR Naviscan (Gamma Medica Inc.) Basic Information
Table 85. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
Table 86. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. CMR Naviscan (Gamma Medica Inc.) Business Overview
Table 88. CMR Naviscan (Gamma Medica Inc.) Recent Developments
Table 89. Curium Basic Information
Table 90. Curium Nuclear Medicine Radioisotopes Product Overview
Table 91. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Curium Business Overview
Table 93. Curium Recent Developments
Table 94. Digirad Basic Information
Table 95. Digirad Nuclear Medicine Radioisotopes Product Overview
Table 96. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Digirad Business Overview
Table 98. Digirad Recent Developments
Table 99. GE Healthcare Basic Information
Table 100. GE Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 101. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Recent Developments
Table 104. Nordion (Canada) Basic Information
Table 105. Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
Table 106. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Nordion (Canada) Business Overview
Table 108. Nordion (Canada) Recent Developments
Table 109. NTP Radioisotopes SOC Basic Information
Table 110. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
Table 111. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. NTP Radioisotopes SOC Business Overview
Table 113. NTP Radioisotopes SOC Recent Developments
Table 114. Positron Basic Information
Table 115. Positron Nuclear Medicine Radioisotopes Product Overview
Table 116. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Positron Business Overview
Table 118. Positron Recent Developments
Table 119. Segami Basic Information
Table 120. Segami Nuclear Medicine Radioisotopes Product Overview
Table 121. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Segami Business Overview
Table 123. Segami Recent Developments
Table 124. Siemens Healthcare Basic Information
Table 125. Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 126. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Siemens Healthcare Business Overview
Table 128. Siemens Healthcare Recent Developments
Table 129. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Nuclear Medicine Radioisotopes Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Nuclear Medicine Radioisotopes Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Nuclear Medicine Radioisotopes Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Nuclear Medicine Radioisotopes Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Radioisotopes Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Radioisotopes Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Nuclear Medicine Radioisotopes Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Nuclear Medicine Radioisotopes Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine Radioisotopes as of 2024)
Table 10. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Nuclear Medicine Radioisotopes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Nuclear Medicine Radioisotopes Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Nuclear Medicine Radioisotopes Sales by Type (K Units)
Table 26. Global Nuclear Medicine Radioisotopes Market Size by Type (M USD)
Table 27. Global Nuclear Medicine Radioisotopes Sales (K Units) by Type (2020-2025)
Table 28. Global Nuclear Medicine Radioisotopes Sales Market Share by Type (2020-2025)
Table 29. Global Nuclear Medicine Radioisotopes Market Size (M USD) by Type (2020-2025)
Table 30. Global Nuclear Medicine Radioisotopes Market Size Share by Type (2020-2025)
Table 31. Global Nuclear Medicine Radioisotopes Price (USD/Unit) by Type (2020-2025)
Table 32. Global Nuclear Medicine Radioisotopes Sales (K Units) by Application
Table 33. Global Nuclear Medicine Radioisotopes Market Size by Application
Table 34. Global Nuclear Medicine Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 35. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2025)
Table 36. Global Nuclear Medicine Radioisotopes Market Size by Application (2020-2025) & (M USD)
Table 37. Global Nuclear Medicine Radioisotopes Market Share by Application (2020-2025)
Table 38. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
Table 39. Global Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 40. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2025)
Table 41. Global Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 42. Global Nuclear Medicine Radioisotopes Market Size Market Share by Region (2020-2025)
Table 43. North America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 44. North America Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 46. Europe Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 49. South America Nuclear Medicine Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 50. South America Nuclear Medicine Radioisotopes Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Nuclear Medicine Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Nuclear Medicine Radioisotopes Market Size by Region (2020-2025) & (M USD)
Table 53. Global Nuclear Medicine Radioisotopes Production (K Units) by Region(2020-2025)
Table 54. Global Nuclear Medicine Radioisotopes Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Nuclear Medicine Radioisotopes Revenue Market Share by Region (2020-2025)
Table 56. Global Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Nuclear Medicine Radioisotopes Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Agfa-Gevaert Group Basic Information
Table 62. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Product Overview
Table 63. Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Agfa-Gevaert Group Business Overview
Table 65. Agfa-Gevaert Group SWOT Analysis
Table 66. Agfa-Gevaert Group Recent Developments
Table 67. Braco Basic Information
Table 68. Braco Nuclear Medicine Radioisotopes Product Overview
Table 69. Braco Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Braco Business Overview
Table 71. Braco SWOT Analysis
Table 72. Braco Recent Developments
Table 73. Cardiarc Basic Information
Table 74. Cardiarc Nuclear Medicine Radioisotopes Product Overview
Table 75. Cardiarc Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Cardiarc Business Overview
Table 77. Cardiarc SWOT Analysis
Table 78. Cardiarc Recent Developments
Table 79. Cardinal Health Basic Information
Table 80. Cardinal Health Nuclear Medicine Radioisotopes Product Overview
Table 81. Cardinal Health Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Cardinal Health Business Overview
Table 83. Cardinal Health Recent Developments
Table 84. CMR Naviscan (Gamma Medica Inc.) Basic Information
Table 85. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Product Overview
Table 86. CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. CMR Naviscan (Gamma Medica Inc.) Business Overview
Table 88. CMR Naviscan (Gamma Medica Inc.) Recent Developments
Table 89. Curium Basic Information
Table 90. Curium Nuclear Medicine Radioisotopes Product Overview
Table 91. Curium Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Curium Business Overview
Table 93. Curium Recent Developments
Table 94. Digirad Basic Information
Table 95. Digirad Nuclear Medicine Radioisotopes Product Overview
Table 96. Digirad Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Digirad Business Overview
Table 98. Digirad Recent Developments
Table 99. GE Healthcare Basic Information
Table 100. GE Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 101. GE Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. GE Healthcare Business Overview
Table 103. GE Healthcare Recent Developments
Table 104. Nordion (Canada) Basic Information
Table 105. Nordion (Canada) Nuclear Medicine Radioisotopes Product Overview
Table 106. Nordion (Canada) Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Nordion (Canada) Business Overview
Table 108. Nordion (Canada) Recent Developments
Table 109. NTP Radioisotopes SOC Basic Information
Table 110. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Product Overview
Table 111. NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. NTP Radioisotopes SOC Business Overview
Table 113. NTP Radioisotopes SOC Recent Developments
Table 114. Positron Basic Information
Table 115. Positron Nuclear Medicine Radioisotopes Product Overview
Table 116. Positron Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Positron Business Overview
Table 118. Positron Recent Developments
Table 119. Segami Basic Information
Table 120. Segami Nuclear Medicine Radioisotopes Product Overview
Table 121. Segami Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Segami Business Overview
Table 123. Segami Recent Developments
Table 124. Siemens Healthcare Basic Information
Table 125. Siemens Healthcare Nuclear Medicine Radioisotopes Product Overview
Table 126. Siemens Healthcare Nuclear Medicine Radioisotopes Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Siemens Healthcare Business Overview
Table 128. Siemens Healthcare Recent Developments
Table 129. Global Nuclear Medicine Radioisotopes Sales Forecast by Region (2026-2033) & (K Units)
Table 130. Global Nuclear Medicine Radioisotopes Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 132. North America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 134. Europe Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Nuclear Medicine Radioisotopes Sales Forecast by Region (2026-2033) & (K Units)
Table 136. Asia Pacific Nuclear Medicine Radioisotopes Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (K Units)
Table 138. South America Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Nuclear Medicine Radioisotopes Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2026-2033) & (K Units)
Table 142. Global Nuclear Medicine Radioisotopes Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Nuclear Medicine Radioisotopes Price Forecast by Type (2026-2033) & (USD/Unit)
Table 144. Global Nuclear Medicine Radioisotopes Sales (K Units) Forecast by Application (2026-2033)
Table 145. Global Nuclear Medicine Radioisotopes Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Medicine Radioisotopes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radioisotopes Market Size (M USD), 2024-2033
Figure 5. Global Nuclear Medicine Radioisotopes Market Size (M USD) (2020-2033)
Figure 6. Global Nuclear Medicine Radioisotopes Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radioisotopes Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine Radioisotopes Product Life Cycle
Figure 13. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2024
Figure 14. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2024
Figure 15. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radioisotopes Revenue in 2024
Figure 18. Industry Chain Map of Nuclear Medicine Radioisotopes
Figure 19. Global Nuclear Medicine Radioisotopes Market PEST Analysis
Figure 20. Global Nuclear Medicine Radioisotopes Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine Radioisotopes Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine Radioisotopes by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine Radioisotopes by Type in 2024
Figure 29. Market Size Share of Nuclear Medicine Radioisotopes by Type (2020-2025)
Figure 30. Market Size Share of Nuclear Medicine Radioisotopes by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine Radioisotopes Market Share by Application
Figure 33. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine Radioisotopes Sales Market Share by Application in 2024
Figure 35. Global Nuclear Medicine Radioisotopes Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine Radioisotopes Market Share by Application in 2024
Figure 37. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine Radioisotopes Market Size Market Share by Region (2020-2025)
Figure 40. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 45. U.S. Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine Radioisotopes Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine Radioisotopes Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine Radioisotopes Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine Radioisotopes Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 55. Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine Radioisotopes Market Size Market Share by Region in 2024
Figure 68. China Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 79. South America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine Radioisotopes Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 82. Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine Radioisotopes Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine Radioisotopes Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine Radioisotopes Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Nuclear Medicine Radioisotopes Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2026-2033)
Figure 111. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2026-2033)
Figure 112. Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Nuclear Medicine Radioisotopes
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Radioisotopes Market Size (M USD), 2024-2033
Figure 5. Global Nuclear Medicine Radioisotopes Market Size (M USD) (2020-2033)
Figure 6. Global Nuclear Medicine Radioisotopes Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Radioisotopes Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nuclear Medicine Radioisotopes Product Life Cycle
Figure 13. Nuclear Medicine Radioisotopes Sales Share by Manufacturers in 2024
Figure 14. Global Nuclear Medicine Radioisotopes Revenue Share by Manufacturers in 2024
Figure 15. Nuclear Medicine Radioisotopes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Nuclear Medicine Radioisotopes Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Radioisotopes Revenue in 2024
Figure 18. Industry Chain Map of Nuclear Medicine Radioisotopes
Figure 19. Global Nuclear Medicine Radioisotopes Market PEST Analysis
Figure 20. Global Nuclear Medicine Radioisotopes Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nuclear Medicine Radioisotopes Market Share by Type
Figure 27. Sales Market Share of Nuclear Medicine Radioisotopes by Type (2020-2025)
Figure 28. Sales Market Share of Nuclear Medicine Radioisotopes by Type in 2024
Figure 29. Market Size Share of Nuclear Medicine Radioisotopes by Type (2020-2025)
Figure 30. Market Size Share of Nuclear Medicine Radioisotopes by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nuclear Medicine Radioisotopes Market Share by Application
Figure 33. Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2020-2025)
Figure 34. Global Nuclear Medicine Radioisotopes Sales Market Share by Application in 2024
Figure 35. Global Nuclear Medicine Radioisotopes Market Share by Application (2020-2025)
Figure 36. Global Nuclear Medicine Radioisotopes Market Share by Application in 2024
Figure 37. Global Nuclear Medicine Radioisotopes Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nuclear Medicine Radioisotopes Sales Market Share by Region (2020-2025)
Figure 39. Global Nuclear Medicine Radioisotopes Market Size Market Share by Region (2020-2025)
Figure 40. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 43. North America Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 45. U.S. Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nuclear Medicine Radioisotopes Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nuclear Medicine Radioisotopes Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nuclear Medicine Radioisotopes Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nuclear Medicine Radioisotopes Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 53. Europe Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 55. Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nuclear Medicine Radioisotopes Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nuclear Medicine Radioisotopes Market Size Market Share by Region in 2024
Figure 68. China Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 79. South America Nuclear Medicine Radioisotopes Sales Market Share by Country in 2024
Figure 80. South America Nuclear Medicine Radioisotopes Market Size and Growth Rate (M USD)
Figure 81. South America Nuclear Medicine Radioisotopes Market Size Market Share by Country in 2024
Figure 82. Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nuclear Medicine Radioisotopes Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nuclear Medicine Radioisotopes Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nuclear Medicine Radioisotopes Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nuclear Medicine Radioisotopes Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nuclear Medicine Radioisotopes Production Market Share by Region (2020-2025)
Figure 103. North America Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nuclear Medicine Radioisotopes Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nuclear Medicine Radioisotopes Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Nuclear Medicine Radioisotopes Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Nuclear Medicine Radioisotopes Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2026-2033)
Figure 111. Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2026-2033)
Figure 112. Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2026-2033)
